Micro-Tech Endoscopy

Micro-Tech Endoscopy

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $40M

Overview

Micro-Tech Endoscopy is a private, commercial-stage medical device company with a 25+ year history in the gastroenterology sector. The company develops and markets a diverse portfolio of single-use and reusable endoscopic devices, including snares, closure devices, needles, and specialized scopes, driven by direct collaboration with clinicians. Its strategy centers on providing value-driven solutions that support the site-of-care shift, improve procedural efficiency, and reduce healthcare costs. Recent acquisitions, like product lines from CONMED, indicate an active strategy to expand its GI portfolio and market reach.

Gastroenterology

Technology Platform

Applied engineering and design expertise for endoscopic devices, focusing on miniaturization, material science (e.g., CoCr alloy), and mechanical innovation for cutting, closure, access, visualization, and biopsy in therapeutic endoscopy.

Funding History

2
Total raised:$40M
Debt$25M
Series A$15M

Opportunities

The strong trend shifting complex GI procedures from hospitals to outpatient ambulatory surgery centers creates a major demand for devices that enable safer, more efficient care in these settings.
Furthermore, the growing adoption of advanced therapeutic techniques like Endoscopic Submucosal Dissection (ESD) opens a premium market segment for specialized, high-performance tools.

Risk Factors

The company faces intense competition from large, established medical device corporations with greater resources and broader portfolios.
Growth is also dependent on favorable and stable reimbursement policies for outpatient endoscopic procedures, which can be subject to change.

Competitive Landscape

Micro-Tech competes in the crowded GI endoscopy market against global giants like Boston Scientific, Olympus, and Medtronic, as well as other specialized players like CONMED. Its differentiation is based on clinician collaboration, cost-effective value proposition, and focused innovation in specific therapeutic device categories like closure and dissection.